• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Advantage Healthcare Holdings Appoints Dinak Nair as Chief Executive Officer

    9/25/24 11:19:00 AM ET
    $AHCO
    $LH
    Medical/Nursing Services
    Health Care
    Medical Specialities
    Health Care
    Get the next $AHCO alert in real time by email

    Advantage Healthcare Holdings ("Advantage" or the "Company"), a regional leader in providing patient-centered healthcare through managing and operating Comprehensive Outpatient Rehabilitation Facilities and Sleep Centers, announced that its Board of Directors has named Dinak (Dino) Nair as its Chief Executive Officer. Mr. Nair assumed leadership of the Company from the prior CEO, Ryan Tong, on September 1, 2024.

    Mr. Nair brings over 20 years of business experience, with more than a decade as a mission-driven leader growing businesses in the healthcare market, especially in homecare, home medical equipment, diagnostic laboratory, and health system partnerships. Mr. Nair most recently served as Vice President, General Manager of the Health Systems Operating Division at Labcorp (NYSE:LH). Previously, Mr. Nair served as Senior Vice President at Thrive Skilled Pediatric Care, and as Vice President of Operations at AdaptHealth (NASDAQ:AHCO). Mr. Nair graduated from the prestigious Bronx High School of Science, holds a B.A. in Business Administration from Sacramento International University, and earned his MBA in Public Accounting from the Tobin College of Business at Saint John's University.

    "We are thrilled to welcome Dino to Advantage," said Timothy Bovard, Chairperson of the Board of Advantage. "Our Board conducted an extensive search and Dino stood out as the ideal fit for us. With his extensive experience in healthcare, particularly sleep and pulmonary therapy, we are confident Dino has the skills and exemplary leadership to lead Advantage as it looks to grow and expand its ability to improve outcomes for more patients through personalized care."

    "I am excited to join the Advantage family, and lead the Company in our continued growth, building on the positive energy that has been established," Mr. Nair said. "I look forward to collaborating closely with our team to execute initiatives to drive improved patient outcomes through greater access, while delivering value to our customers and stakeholders."

    "On behalf of the Board of Directors, we would like to thank Ryan for his leadership," said Mr. Bovard. "He led the Company through some challenging times and is delivering a business poised for growth to Dino."

    About Advantage Healthcare Holdings

    Advantage is a regional leader in managing and operating Comprehensive Outpatient Rehabilitation Facilities and Sleep Centers (Sleep Labs). The Company provides a wide array of services, including Physical Therapy, Occupational Therapy, Pulmonary Rehabilitation, In-Lab Sleep Testing, Home Sleep Testing, and Remote Patient Monitoring. Advantage also runs an Accredited Sleep Technologist Education Program (A-STEP).

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240925779746/en/

    Get the next $AHCO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AHCO
    $LH

    CompanyDatePrice TargetRatingAnalyst
    Labcorp Holdings Inc.
    $LH
    4/2/2025$276.00Buy
    Redburn Atlantic
    Labcorp Holdings Inc.
    $LH
    3/4/2025$250.00 → $300.00Neutral → Buy
    Citigroup
    Labcorp Holdings Inc.
    $LH
    1/7/2025$260.00 → $265.00In-line → Outperform
    Evercore ISI
    Labcorp Holdings Inc.
    $LH
    12/10/2024$265.00 → $275.00Buy
    Jefferies
    Labcorp Holdings Inc.
    $LH
    10/30/2024Hold → Buy
    HSBC Securities
    Labcorp Holdings Inc.
    $LH
    10/1/2024$235.00Neutral
    Piper Sandler
    Labcorp Holdings Inc.
    $LH
    3/25/2024$250.00Hold → Buy
    Argus
    Labcorp Holdings Inc.
    $LH
    2/26/2024$260.00Outperform
    Leerink Partners
    More analyst ratings